<DOC>
	<DOC>NCT00583258</DOC>
	<brief_summary>Patients who present for the first time to Emergency Room with renal colic due to a distal ureteral calculus (as diagnosed with spiral CT scan and KUB) will be randomized to receive Xatral 10mg po once a day or placebo once discharged from the ER. The purpose of this study is to assess if patients treated with Xatral will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.</brief_summary>
	<brief_title>A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones</brief_title>
	<detailed_description />
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>first presentation to ER with renal colic secondary to a distal ureteral stone diagnosed on spiral CT scan stone radiopaque on KUB, distal to the sacroiliac joint patient suitable for discharge from ER patient willing to return for followup on a weekly basis for maximum 4 visits more than one ureteral calculi radiolucent stones or cystine stones prior ipsilateral calculus or ureteral surgery congenital anomalies of the ureter patients presents with an absolute indication for intervention allergy or contraindication to NSAIDs (history of orthostatic hypotension, current systolic BP &lt;90 mmHg) patient currently taking an alphablocker hepatic insufficiency pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>